Document:

<PAGE>

                                  Exhibit 10(l)

    Portions of this document indicated by an ++ have been omitted and filed
       separately with the Securities and Exchange Commission pursuant to
            a request for confidential treatment of such information

                        EXCLUSIVE DISTRIBUTION AGREEMENT

         THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this "Agreement") is made and
entered into as of August 15, 2001 (the "Effective Date"), by and between
INTELLIGENT SYSTEMS SOFTWARE, INC., a Florida corporation ("Manufacturer"), and
INSTRUMENTARIUM IMAGING INC., a Delaware corporation ("Distributor").

                                   WITNESSETH:

         In consideration of the mutual covenants and conditions herein
contained, and intending to be legally bound hereby, the parties mutually agree
as follows:

1. Products and Territory.

         1.1 Manufacturer hereby appoints Distributor as its exclusive
authorized distributor in the United States, during the term of this Agreement,
for the sale of Manufacturer's MammoReader system (the "MammoReader") and the
other products described on Schedule A attached hereto (the "Products"), as
revised and updated from time to time upon the mutual agreement of Manufacturer
and Distributor. Distributor shall not, without the prior written consent of
Manufacturer, sell, market or distribute any version of any Product other than
the version Manufacturer shall designate from time to time as its most current
version.

         1.2 Distributor shall use its commercially reasonable best efforts to
promote and sell the Products to the maximum number of customers for
installation in the United States. Distributor agrees not to knowingly sell any
Products for installation outside of the United States. In the event Distributor
receives an inquiry from a potential purchaser of Products for installation
outside of the United States, Distributor agrees to promptly forward the inquiry
to Manufacturer.

         1.3 Distributor hereby represents and warrants to Manufacturer that
Distributor has sufficient financial resources, experience and qualified
personnel to perform in full all of its financial, sales and operational
obligations contained in this Agreement.

         1.4 Distributor shall supply to Manufacturer, on a monthly basis, a
12-month rolling forecast of sales of Products (the "Forecast"). The first
Forecast shall be delivered upon commencement of the first 12-Month Period and
shall be for the period of the next three full calendar months following such
date. Commencing on the first day of the calendar month following such
commencement date, the Distributor shall provide a Forecast on the first day of
each month for the third month thereafter. Each Forecast shall not be considered
to constitute firm orders but rather non-binding forecasts based on
Distributor's commercially reasonable estimates.

<PAGE>

2.       Period Definitions.

         As used herein, "6-Month Period" and "9-Month Period" shall mean the 6
months and 9 months, respectively, following the date of U.S. Food and Drug
Administration ("FDA") approval of the sale of the MammoReader in the United
States (the "Approval Date"). As used herein, "12-Month Period" shall mean the
12 months following the date of such approval and the subsequent 12-month
periods following such initial 12-month period. "Second Year 6-Month Period" and
"Third Year 6-Month Period" shall mean the 6 months periods beginning on the
commencement date of the second 12-Month Period and the third 12-Month Period,
respectively.

3.       Prices and Payment.

         3.1 Distributor shall order Products from Manufacturer by submitting a
written purchase order identifying the type and number of units of Products
ordered, requested delivery dates and any export/import information required to
enable Manufacturer to fill the order (the "Purchase Order"). All orders for
Products are subject to acceptance by Manufacturer at Manufacturer's office at
6405 Congress Avenue, Boca Raton, Florida 33487. Manufacturer shall have no
liability to Distributor with respect to purchase orders which are not accepted.

         3.2 The price of each Product sold to Distributor shall be the list
price therefor set forth on Schedule A, less ++. Such list price may be
decreased from time to time by Manufacturer in its sole discretion upon 30 days
prior written notice to Distributor. Such list prices may be increased from time
to time by mutual agreement of Manufacturer and Distributor.

         3.3 In consideration of the exclusive distributorship granted hereby,
Distributor agrees to resell the Products for the list prices set forth on
Schedule A.

         3.4 The ultimate shipment of orders to Distributor shall be subject to
the right and ability of Manufacturer to make such sales and obtain required
licenses and permits, under all applicable statutes, rules and regulations of
the United States and agencies or instrumentalities thereof, including the FDA,
presently in effect or which may be in effect hereafter.

         3.5 (a) Distributor hereby agrees (i) to comply with decrees, statutes,
rules and regulations of the United States and agencies or instrumentalities
thereof in the performance of its duties under this Agreement; (ii) to maintain
the necessary records to comply with such statutes, rules and regulations; and
(iii) to indemnify and hold harmless Manufacturer from any and all fines,
damages, losses, costs and expenses (including reasonable attorneys' fees)
incurred by Manufacturer as a result of any breach of this subsection by
Distributor.

             (b) Manufacturer hereby agrees (i) to comply with decrees,
statutes, rules and regulations of the United States and agencies or
instrumentalities thereof in connection with the manufacture and sale of the
Products and in the performance of its duties under this Agreement, (ii) to
maintain the necessary records to comply with such statutes, rules and
regulations; and (iii) to indemnify and hold harmless Distributor from any and
all fines, damages, losses, costs and expenses (including reasonable attorneys'
fees) incurred by Distributor as a result of any breach of this subsection by
Manufacturer.

[++ represents confidential treatment request]

                                       2
<PAGE>

         3.6 Unless Distributor requests otherwise and Manufacturer agrees in
writing, all Products ordered by Distributor shall be packed for shipment and
storage in accordance with Manufacturer's standard commercial practices, either
for shipment to Distributor or for direct drop shipment directly to purchasers
from Manufacturer. Manufacturer shall deliver the Products into the possession
of a common carrier designated by Distributor and reasonably acceptable to
Manufacturer, no later than the date specified for such delivery on the relevant
purchase order for such Products. Risk of loss and damage to a Product shall
pass to Distributor upon the delivery of such Product to the common carrier
F.O.B. Manufacturer's Boca Raton, Florida shipping facility. All claims for
non-conforming shipments must be made in writing to Manufacturer within 10 days
of the completion of the installation of the Products, but in no instance later
than 21 days after such delivery of the Product to the common carrier.

         3.7 All amounts due and payable with respect to Products delivered by
Manufacturer shall be paid in full within 30 days after the date of
Manufacturer's invoice covering such Products. All such amounts shall be paid in
United States dollars by wire transfer, to such bank or account as Manufacturer
may from time to time designate in writing to Distributor, or by corporate
check. No part of any amount payable to Manufacturer hereunder may be reduced
due to any counterclaim, set-off, adjustment or other right which Distributor
might have against Manufacturer, any other party or otherwise. Any payments not
paid by Distributor within the 30-day period shall bear interest at the rate of
one percent per month commencing on the close of business the day immediately
following the day on which the payment is due.

         3.8 In the event of any discrepancy between any purchase order accepted
by Manufacturer and this Agreement, the terms of this Agreement shall govern.

         3.9 Distributor shall be responsible for all expenses of sale and
shipment of Products, including freight, insurance, sales taxes and customs
duties. Distributor shall reimburse Manufacturer for any such expenses paid by
Manufacturer upon receipt of Manufacturer's invoices therefor.

         3.10 Manufacturer agrees to be responsible to pay any rebates payable
to group purchasing organizations with respect to resales of Products made by
Distributor, provided, that Manufacturer is provided a copy of the group
purchasing organization's invoice at the time Manufacturer accepts the purchase
order for such Products.

4.       Other Obligations of Distributor.

         4.1 Distributor shall employ competent and experienced personnel to
market the Products.

         4.2 Distributor shall, at its own expense, install and set up all of
the Products sold by it at its customers' premises and train the customers'
personnel in the proper operation of the Products.

         4.3 Distributor shall advertise and otherwise promote the sale of the
Products, including, without limitation, the establishment of promotional
campaigns, advertisement of the Products in trade journals and attendance at
trade shows, and shall, within 30 days of the commencement of each 12-Month
Period, provide Manufacturer with Distributor's promotional strategic plan (and
any amendments thereto) for Manufacturer's review.

                                       3
<PAGE>

         4.4 Distributor shall be required to use the brand name of the Product,
as chosen solely in the discretion of Manufacturer (the "Brand Name"), on all
packaging, promotional materials, advertising materials, press releases,
articles and any other written materials in which the Product appears or is
mentioned. Anytime the Brand Name is required to appear, Manufacturer's name
shall also appear clearly indicating that Manufacturer is the manufacturer of
the Product.

5.       Manufacturer's Obligations.

         Manufacturer shall provide Distributor, without charge, with such
marketing, technical and sales assistance as Manufacturer may in its reasonable
discretion consider necessary to assist with the promotion of the Products.
Manufacturer shall also provide Distributor with such amount of Product training
as Manufacturer determines is reasonably necessary to assist Distributor in
effectively carrying out its obligations under this Agreement. Manufacturer
shall be responsible for developing and printing sales and marketing literature
for the Products and shall provide Distributor with reasonable quantities of
such literature to facilitate Distributor's sales efforts.

6.       Relationship of the Parties.

         6.1 Distributor shall be considered to be an independent contractor of
Manufacturer. The relationship between Manufacturer and Distributor shall not be
construed to be that of employer and employee, nor to constitute a partnership,
joint venture or agency of any kind.

         6.2 Distributor shall pay all of its expenses, including without
limitation all travel, lodging and entertainment expenses incurred in connection
with its services hereunder and all training provided hereunder. Manufacturer
shall not reimburse Distributor for any expenses.

         6.3 Neither party shall have the right to enter into any contracts or
commitments in the name of, or on behalf of, the other party, or to bind the
other party in any respect whatsoever.

7.       Trademarks, Service Marks and Trade Names.

         Distributor may use Manufacturer's trademarks, trade names and service
marks (the "Trademarks") on a non-exclusive basis only for the duration of this
Agreement and solely for display or advertising purposes in connection with
selling and distributing the Products in accordance with this Agreement. In the
event Distributor becomes aware of any action proposed to be taken by a third
party which may, in Distributor's judgment, in any way impair the rights of
Manufacturer in Manufacturer's Intellectual Property (as defined below),
Distributor agrees to promptly notify Manufacturer of such proposed action.
Distributor shall promptly and completely apprise Manufacturer of any actual,
threatened or suspected infringement of any Intellectual Property rights of
Manufacturer of which Distributor becomes aware. Except as provided above,
Distributor has no rights in the Intellectual Property relating to the Products
or of any goodwill associated therewith and Distributor agrees that, except as
expressly provided in this Agreement, it shall not acquire any rights in respect
thereof and that all such rights and goodwill are, and shall remain, vested in
Manufacturer. "Intellectual Property" shall mean all intellectual property
rights of Manufacturer from time to time, including the Trademarks, any patents,
design rights or registered design and any applications throughout the world or
the right to apply for any of the foregoing. Intellectual Property further
includes copyright, know-how, confidential information, any business name,
trading name or style or brand name, and any merchandising rights. Distributor
hereby agrees not to register or cause to be registered any Trademarks in
Distributor's name. Without prejudice to the right of Distributor or any third
party to challenge the validity of any Intellectual Property of Manufacturer,
Distributor shall not otherwise do or authorize any third party to do any act
which would or might invalidate or be inconsistent with any Intellectual
Property of Manufacturer and shall not omit or authorize any third party to omit
or do any act which, by its omission, would have such effect or character.

                                       4
<PAGE>

8.       Covenant Not to Compete.

         Commencing on the Approval Date and continuing for the term of this
Agreement, Distributor shall not market, directly or indirectly, products which
are competitive with the Products.

9.       Limited Warranty.

         9.1 Manufacturer warrants that the Products will be free from material
defects for a period of one year from the date of shipment and will meet
Manufacturer's written specifications. Manufacturer's sole responsibility under
this warranty shall be, at Manufacturer's option, to replace defective Products
or parts thereof.

         9.2 Distributor shall not obligate or purport to obligate Manufacturer
by issuing or making any affirmations, representations, warranties or guaranties
with respect to the Products to any third party, other than the foregoing
standard warranty, which warranty shall be extended to all purchasers of
Products from Distributor. At Distributor's request, Manufacturer shall provide
Distributor with copies of Manufacturer's standard warranty for distribution by
Distributor to purchasers of the Products.

         9.3 Under no circumstances shall the warranty set forth in Section 9.1
above apply to any Product which has been used outside the field of use or in
violation of this Agreement or to any Product which has been customized or
modified, damaged, misused or improperly installed or applied. Notwithstanding
any other provision in this Agreement, Manufacturer shall not be held
responsible for any damage which may result from a defective Product except for
the repair or replacement of such Products.

         9.4 THE PROVISIONS OF THE FOREGOING WARRANTY ARE IN LIEU OF ANY OTHER
WARRANTY, WHETHER EXPRESS OR IMPLIED, WRITTEN OR ORAL (INCLUDING ANY WARRANTY OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE).

                                       5
<PAGE>

10.      Limitation on Liability.

         IN NO EVENT SHALL MANUFACTURER BE LIABLE TO DISTRIBUTOR OR ANY OTHER
PERSON OR ENTITY FOR SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING,
BUT NOT LIMITED TO, LOSS OF PROFITS, LOSS OF DATA OR LOSS OF USE DAMAGES)
ARISING OUT OF THE MANUFACTURE, SALE OR USE OF THE PRODUCTS, EVEN IF
MANUFACTURER HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR LOSSES.

11.      Indemnification.

         11.1 Distributor hereby agrees to indemnify, defend and hold harmless
Manufacturer, its affiliates and all officers, directors, employees and agents
thereof from all liabilities, claims, damages, losses, costs, expenses, demands,
suits and actions (including without limitation attorneys' fees, expenses and
settlement costs) arising out of or related to (i) any failure by Distributor to
perform its obligations hereunder, and (ii) any other act or omission of
Distributor and/or its agents, employees or others for which it is responsible.

         11.2 Manufacturer hereby agrees to indemnify, defend and hold harmless
Distributor, its affiliates and all officers, directors, employees and agents
thereof, from all liabilities, claims, damages, losses, costs, expenses,
demands, suits and actions (including without limitation attorneys' fees,
expenses and settlement costs) arising out of or related to (i) any defects in
the Products, (ii) any breach of warranty, (iii) any product liability claims
and similar matters, (iv) any failure by Manufacturer to perform its obligations
hereunder, (v) any other act or omission of Manufacturer and/or its agents,
employees or others for which it is in law responsible, and (vi) infringement of
Intellectual Property rights of others or Manufacturer's Trademarks resulting
from Distributor's sale of the Products. During the term hereof from and after
the Approval Date, Manufacturer shall maintain a policy of general public and
product liability insurance, including contractual liability for its
indemnification obligations hereunder, protecting it and Distributor in an
amount of not less than $2,000,000 single limit coverage and naming Distributor
as an additional insured. Upon request of Distributor, Manufacturer shall
provide Distributor with copies of such insurance certificates establishing the
existence thereof.

12.      Term and Termination.

         12.1 Term. The term of this Agreement shall commence on the Effective
Date and shall terminate at the end of the third 12-Month Period unless
terminated earlier pursuant to the terms of this Section 12. Within 10 days
after any termination of this Agreement, Distributor shall return to
Manufacturer all unused sales materials, product literature and other material
pertaining to Manufacturer or the Products, which were paid for or provided by
Manufacturer.

         12.2 ++

         12.3 Termination. This Agreement may be terminated:

              (a) ++

[++ represents confidential treatment request]

                                       6
<PAGE>

              (b) by Manufacturer, in the event that Distributor fails to make
any payment within 30 days from the date of Manufacturer's invoice for shipped
Products;

              (c) by Manufacturer, upon the occurrence of a change in control or
management personnel of Distributor, which has or, in the reasonable opinion of
Manufacturer, could have, a material adverse effect on the business, prospects
or operations of Distributor and the failure of Distributor to promptly pursue
(within 60 days after receiving written notice thereof from Manufacturer) a
remedy designed to cure (in the sole and absolute judgment of Manufacturer)
Manufacturer's objections to such change;

              (d) by Manufacturer, upon an attempted assignment, delegation,
sublicense or transfer, whether by operation of law, merger, sale of any
substantial portion of Distributor's assets or business or otherwise, of this
Agreement by Distributor without the prior written consent of Manufacturer;

              (e) by Distributor, in the event it is determined by final
judgment of a court of competent jurisdiction in the United States that the
MammoReader materially infringes one or more U.S. patents held by others;

              (f) by Distributor, in the event the FDA has not granted approval
of the sale of the MammoReader in the United States within 12 months after the
Effective Date;

              (g) by Distributor, in the event the FDA issues an order or decree
prohibiting the sale or use of the MammoReader in the United States;

              (h) by Distributor, in the event of substantial and continuing
failure of the MammoReader (generally, not particular units) to work in the
manner described in literature regarding the system prepared by Manufacturer;

              (i) by the non-breaching party, upon the occurrence of a material
breach of this Agreement by the other party and the failure of the other party
to cure such breach within 30 days of receipt of written notice thereof from the
non-breaching party; and

              (j) by the other party, in the event of the filing of a petition
in bankruptcy, insolvency or reorganization against or by a party which is not
dismissed within 30 days of filing.

         12.4 In the event of a termination of this Agreement or upon the
expiration of this Agreement pursuant to Section 12.1 above, Manufacturer shall
not have any obligation to Distributor, or to any employee of Distributor, for
compensation or for damages of any kind, whether on account of the loss by
Distributor or such employee of present or prospective sales, investments,
compensation or goodwill.

         12.5 Termination of this Agreement shall not affect the obligation of
Distributor to pay Manufacturer all amounts owing or to become owing as a result
of Products tendered or delivered to Distributor on or before the date of such
termination, as well as interest thereon to the extent any such amounts are paid
after the date they became or will become due pursuant to this Agreement.

                                       7
<PAGE>

         12.6 Notwithstanding anything else in this Agreement to the contrary,
the parties agree that Sections 9, 10, 11, 12, 16 and 17 shall survive the
termination or expiration of this Agreement, as the case may be, to the extent
required thereby for the full observation and performance by any or all of the
parties hereto.

13.      Assignment.

         Distributor may not assign, delegate, sublicense or transfer, whether
by operation of law, merger, sale of any substantial portion of Distributor's
assets or business or otherwise, this Agreement without the prior written
consent of Manufacturer, and any attempted assignment, delegation, sublicense or
transfer by Distributor without such written consent shall be void and of no
effect. Manufacturer may fully assign, delegate, sublicense or transfer, whether
by operation of law or otherwise, this Agreement without Distributor's consent.
This Agreement shall inure to the benefit of the successors and assigns of
Manufacturer.

14.      Notice.

         All notices given under this Agreement shall be in writing and shall be
addressed to the parties at their respective addresses set forth below:

         If to Manufacturer:

                  Intelligent Systems Software, Inc.
                  6405 Congress Avenue
                  Boca Raton, Florida  33487
                  Attention:  W. Kip Speyer, President
                  Telecopy Number:  561-994-0881

         If to Distributor:

                  Instrumentarium Imaging Inc.
                  300 West Edgerton Avenue
                  Milwaukee, Wisconsin  53207
                  Attention:  Michael Palazzola, President
                  Telecopy Number:  414-481-8665

All notices shall be given in person, by overnight courier or by telecopy. All
notices shall be deemed given on the date received by the addressee.

15.      Waiver.

         None of the conditions or provisions of this Agreement shall be held to
have been waived by any act or knowledge on the part of either party, except by
an instrument in writing signed by a duly authorized officer or representative
of such party. Further, the waiver by either party of any right hereunder or the
failure to enforce at any time any of the provisions of this Agreement, or any
rights with respect thereto, shall not be deemed to be a waiver of any other
rights hereunder or any breach or failure of performance of the other party.

                                       8
<PAGE>

16.      Construction of Agreement and Resolution of Disputes.

         16.1 This Agreement, and the performance of the parties hereto shall be
construed and governed according to the laws of Florida, applicable to contracts
made and to be fully performed therein. Any dispute, controversy or claim
arising out of or relating to this Agreement or to a breach hereof, including
its interpretation, performance or termination, shall be finally resolved by
arbitration. The arbitration shall be conducted by three arbitrators, one to be
appointed by Manufacturer, one to be appointed by Distributor and a third being
nominated by the two arbitrators so selected or, if they cannot agree on a third
arbitrator, by the President of the American Arbitration Association. In the
event any such dispute, controversy or claim involves a claim of damages for
$100,000 or less, the arbitration shall be conducted by one arbitrator appointed
by Manufacturer and Distributor or, if they cannot agree on an arbitrator, by
the President of the American Arbitration Association.

         16.2 The arbitration shall be in accordance with the rules of the
American Arbitration Association, which shall administer the arbitration and act
as appointing authority. The arbitration, including the rendering of the award,
shall take place in Palm Beach County, Florida, and shall be the exclusive forum
for resolving such dispute, controversy or claim. For the purposes of this
arbitration, the provisions of this Agreement and all rights and obligations
thereunder shall be governed and construed in accordance with the laws of the
State of Florida. The decision of the arbitrators shall be binding upon the
parties hereto, and the expense of the arbitration (including without limitation
the award of attorneys' fees to the prevailing party) shall be paid as the
arbitrators determine. The decision of the arbitrators shall be executory, and
judgment thereon may be entered by any court of competent jurisdiction.

         16.3 Notwithstanding anything contained in this Section to the
contrary, each party shall have the right to institute judicial proceedings
against the other party or anyone acting by, through or under such other party,
in order to enforce the instituting party's rights hereunder through reformation
of contract, specific performance, injunction or similar equitable relief.

17.      Confidentiality Maintained.

         17.1 Distributor agrees that Manufacturer has a proprietary interest in
any information provided to Distributor by Manufacturer, whether in connection
with this Agreement or otherwise, whether in written or oral form, which is (i)
a trade secret, confidential or proprietary information; and (ii) not publicly
known (hereinafter referred to as "Proprietary Information"). Distributor shall
disclose the Proprietary Information only to those of its agents and employees
to whom it is necessary in order properly to carry out their duties as limited
by the terms and conditions hereof. Both during and after the term of this
Agreement, all disclosures by Distributor to its agents and employees shall be
held in strict confidence by such agents and employees. During and after the
term of this Agreement, Distributor, its agents and employees shall not use the
Proprietary Information for any purpose other than in connection with
Distributor's sale and distribution of the Products pursuant to this Agreement.
Distributor shall, at its expense, return to Manufacturer the Proprietary
Information as soon as practicable after the termination or expiration of this
Agreement. All such Proprietary Information shall remain the exclusive property
of Manufacturer during the term of this Agreement and thereafter.

                                       9
<PAGE>

         17.2 Notwithstanding anything contained in this Agreement to the
contrary, Distributor shall not be liable for a disclosure of the Proprietary
Information of Manufacturer, if the information so disclosed: (i) was in the
public domain at the time of disclosure without breach of this Agreement; or
(ii) was known to or contained in the records of Distributor from a source other
than Manufacturer at the time of disclosure by Manufacturer to Distributor and
can be so demonstrated; or (iii) was independently developed and is so
demonstrated promptly upon receipt of the documentation and technology by
Distributor; or (iv) becomes known to Distributor from a source other than
Manufacturer without breach of this Agreement by Distributor and can be so
demonstrated; or (v) must be disclosed pursuant to a contract or subcontract
with a governmental agency in order to obtain/retain a procurement contract; or
(vi) was disclosed pursuant to court order or as otherwise compelled by law.

18.      No Rights by Implication.

         No rights or licenses with respect to the Products or the Trademarks
are granted or deemed granted hereunder or in connection herewith, other than
those rights expressly granted in this Agreement.

19.      Responsibility for Taxes.

         Taxes now or hereafter imposed with respect to the transactions
contemplated hereunder (with the exception of income taxes or other taxes
imposed upon Manufacturer and measured by the gross or net income of
Manufacturer) shall be the responsibility of Distributor, and if paid or
required to be paid by Manufacturer, the amount thereof shall be added to and
become a part of the amounts payable by Distributor hereunder.

                                       10
<PAGE>

20.      Modification of Products.

         Distributor may not customize, modify or have customized or modified
any Product unless it obtains the prior written consent of Manufacturer, which
consent may be withheld in the sole and absolute discretion of Manufacturer. Any
unauthorized customizing or modification of any Product by Distributor or any
third party shall fully relieve Manufacturer from any obligation it would
otherwise have had with respect to such Product under the warranties described
in Section 9 herein. Distributor may not incorporate any of the Products in its
own products.

21.      Force Majeure.

         21.1 Neither Manufacturer nor Distributor shall be liable in damages,
or shall be subject to termination of this Agreement by the other party, for any
delay or default in performing any obligation hereunder if that delay or default
is due to any cause beyond the reasonable control and without fault or
negligence of that party; provided that, in order to excuse its delay or default
hereunder, a party shall notify the other of the occurrence or the cause,
specifying the nature and particulars thereof and the expected duration thereof.
All obligations of both parties shall return to being in full force and effect
upon the termination of such occurrence or cause (including without limitation
any payments which became due and payable hereunder prior to the termination of
such occurrence or cause).

         21.2 For the purposes of this Section, a "cause beyond the reasonable
control" of a party shall include, without limiting the generality of the
phrase, any act of God, act of any government or other authority or statutory
undertaking, industrial dispute, hurricane, fire, explosion, accident, power
failure, flood, riot or war (declared or undeclared).

22.      Compliance with Laws.

         Each of Distributor and Manufacturer covenants that all of its
activities under or pursuant to this Agreement shall comply with all applicable
laws, rules and regulations.

23.      Severability.

         If any provision of this Agreement is declared invalid or unenforceable
by a court having competent jurisdiction, it is mutually agreed that this
Agreement shall endure except for the part declared invalid or unenforceable by
order of such court. The parties shall consult and use their best efforts to
agree upon a valid and enforceable provision which shall be a reasonable
substitute for such invalid or unenforceable provision in light of the intent of
this Agreement.

24.      Counterparts.

         This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same instrument.

25.      Entire Agreement.

         This Agreement supersedes and cancels any previous agreements or
understandings, whether oral, written or implied, heretofore in effect and sets
forth the entire agreement between Manufacturer and Distributor with respect to
the subject matter hereof.

26.      Amendment.

         This Agreement may be amended only by written agreement referred to
this Agreement executed by Manufacturer and Distributor.

                            (SIGNATURE PAGE FOLLOWS)

                                       11
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have signed this Agreement as of
the date first above written.

                                             MANUFACTURER:

                                             INTELLIGENT SYSTEMS SOFTWARE, INC.

                                             By:      \s\ W. Kip Speyer
                                                -----------------------------
                                             Name:    W. Kip Speyer
                                             Title:   President

                                             DISTRIBUTOR:

                                             INSTRUMENTARIUM IMAGING INC.

                                             By:      \s\ Michael Palazzola
                                                -----------------------------
                                             Name:    Michael Palazzola
                                             Title:   President

                                       12
<PAGE>

                                   Schedule A

Product Description                                                  List Price
-------------------                                                  ----------
1. MammoReader                                                         $99,500
2. MammoReader (dual scanner model)                                   $149,500<PAGE>

                                  Exhibit 10(m)

    Portions of this document indicated by an ++ have been omitted and filed
       separately with the Securities and Exchange Commission pursuant to
            a request for confidential treatment of such information

                                LICENSE AGREEMENT

This License Agreement, dated February 18, 2003, ("Agreement") is entered into
by and between Scanis, Inc., a corporation organized and existing under the laws
of the State of California, having an office and place of business at 1111
Triton Drive, Suite 201, Foster City, CA 94404 (hereinafter referred to as
"SCANIS") and iCAD, Inc., a corporation organized and existing under the laws of
the State of Delaware, having an office and place of business at 4 Townsend
West, Suite 17, Nashua, NH 03063 (hereinafter referred to as "ICAD").

                                    STATEMENT

SCANIS is the owner of all right, title and interest in and to U.S. Patent
No. 5,212,637 of May 18, 1993, entitled "Method Of Investigating Mammograms For
Masses And Calcifications, And Apparatus For Practicing Such Method", Canadian
Patent No. 2,069,429 and Japanese Patent No. 3,121,008. SCANIS desires to grant
and ICAD desires to receive a license under such patents and any related patents
to manufacture, market, and sell products incorporating the invention claimed in
such patents and any related patents.

ICAD and its Subsidiaries also develop, manufacture and sell medical film
digitizers suitable for use in medical imaging and analysis, and uniquely
applicable to SCANIS' business and business objectives. Prior to this Agreement,
ICAD retained the right to limit or deny SCANIS access to such current and
prospective digitizer products, actions by ICAD that would substantially enhance
ICAD's competitive position with respect to SCANIS in SCANIS' key markets.
Failure of SCANIS to acquire such digitizer products from ICAD is deemed likely
by SCANIS to materially and adversely affect SCANIS business plan, operations
and financial performance.

By a concurrent Original Equipment Manufacturing Supply Agreement, dated the
same date as this Agreement, (the "OEM Agreement") between SCANIS and Howtek
Devices Corporation, a wholly-owned subsidiary of ICAD ("HOWTEK"), ICAD makes
such digitizer products available to SCANIS, substantially enhancing SCANIS'
competitive position with respect to ICAD in ICAD's key markets. The parties
acknowledge that making ICAD digitizers available to SCANIS is expected to
materially increase sales of computer aided detection systems by SCANIS and
materially decrease sales of computer aided detection systems by ICAD, and
therefore represents a significant, material and continuing element of
consideration herein.

Additionally, in bargaining herein, the parties have agreed to certain credits
to be granted by ICAD to SCANIS with respect to the purchase of HOWTEK
digitizers over the term of this Agreement.

Now, therefore, in consideration of the mutual promises herein contained, the
parties agree as follows:

      1.    DEFINITIONS. As used in this Agreement, the following terms shall
            have the meaning indicated below:

            a.    "Licensed Patents" shall mean those patents identified in
                  Exhibit 1 to this Agreement.

            b.    "Licensed Patent Rights" shall mean the rights which are held
                  or which come to be held by SCANIS and its successors and
                  assigns by virtue of its ownership of the Licensed Patents.

            c.    "Licensed Products" shall include scanners, digitizers, and
                  other equipment, software, firmware and methods for medical
                  imaging and/or analysis, whether those products presently
                  exist or are developed in the future, that contain, reduce to
                  practice or otherwise incorporate some or all inventions that
                  are subject to the Licensed Patent Rights.

                                       1
<PAGE>
            d.    "Subsidiary" shall mean any business entities (1) of which, as
                  of the Effective Date of this Agreement, ICAD owns more than
                  50% of the voting ownership interests or has the ability to
                  elect a majority of the members of the governing body of such
                  business entity; and (2) which may be organized by iCAD,
                  subsequent to the Effective Date of this Agreement, for bone
                  fide organizational, manufacturing, legal, liability
                  management or tax management purposes, or to comply with
                  foreign laws, regulations or market requirements.

            e.    "Effective Date" shall mean the date on which the last party
                  to this Agreement executes this Agreement or the date upon
                  which all of the parties to the OEM Agreement have executed
                  that agreement, whichever is the last to occur.

      2.    WARRANTIES.

            a.    SCANIS warrants and represents as follows:

                  i.    that it is the sole and exclusive owner of the entire
                        right, title, and interest in and to the Licensed Patent
                        Rights and to the invention disclosed and claimed
                        therein;

                  ii.   that it has the right to enter into this Agreement with
                        ICAD;

                  iii.  that there are no liens, conveyances, mortgages,
                        assignments, encumbrances or other agreements which
                        would prevent or impair the full and complete exercise
                        by ICAD and its Subsidiaries of all rights and licenses
                        granted by SCANIS in this Agreement;

                  iv.   that it has not entered into, and shall not enter into,
                        any agreements which would interfere with the rights and
                        licenses granted pursuant to this License Agreement for
                        the full term of this Agreement;

                  v.    that as of the date of this Agreement, it does not own
                        or control any other patent or patent application
                        relating to scanners or digitizers or related software
                        or methods for medical imaging;

                  vi.   that as of the Effective Date of this License Agreement,
                        it has not received an assertion from any third party,
                        nor an opinion from its counsel, that the Licensed
                        Patent Rights are invalid or unenforceable for any
                        reason.

            b.    ICAD warrants and represents as follows:

                  i.    that it has the right to enter into this Agreement with
                        SCANIS and that HOWTEK has the right to enter into the
                        OEM Agreement with SCANIS;

                  ii.   that ICAD's entry into this Agreement and the
                        performance of ICAD's obligations under this Agreement
                        will not constitute a breach of or default under of any
                        agreement to which it is bound or a violation of any
                        court or administrative order or decree to which it is
                        subject;

                  iii.  that HOWTEK's entry into the OEM Agreement and the
                        performance of HOWTEK's obligations under that agreement
                        will not constitute a breach of or default under of any
                        agreement to which it is bound or a violation of any
                        court or administrative judgment or order to which it is
                        subject;

                  iv.   except with respect to that patent litigation commenced
                        by R2 Technologies, et al, against iCAD, that neither
                        ICAD nor HOWTEK is the subject of any pending or
                        threatened suit or administrative action nor, to the
                        knowledge of ICAD, any investigation which may result in
                        a judgment or order that would reasonably be expected to
                        prohibit or limit ICAD or HOWTEK from performing their
                        respective obligations under this Agreement or the OEM
                        Agreement;

                  v.    that Exhibit 2 to this Agreement sets forth a complete
                        list of all business entities that are Subsidiaries of
                        ICAD as of the Effective Date.

                                       2
<PAGE>

      3.    LICENSE, RELEASE AND COVENANT.

            a.    SCANIS, on behalf of itself and its successors and assigns in
                  the Licensed Patent Rights, hereby grants to ICAD and its
                  Subsidiaries a non-exclusive, world-wide, right and license to
                  make, have made, use, sell, offer for sale, lease, import,
                  export, or otherwise dispose of Licensed Products throughout
                  the world.

            b.    SCANIS hereby releases and discharges ICAD as well as any end
                  users, distributors, customers, dealers, licensees and
                  suppliers of ICAD throughout the world, whether direct or
                  indirect, immediate or remote, from any and all claims for
                  infringement of the Licensed Patent Rights which SCANIS had at
                  any time prior to the Effective Date or may have in the future
                  based on acts before the Effective Date under the Licensed
                  Patents Rights arising out of the manufacture, use, license,
                  sale, offer for sale, lease, import, export, or other
                  disposition of Licensed Products manufactured, sold, offered
                  for sale, leased, imported, exported or otherwise disposed of
                  by or on behalf of ICAD or its Subsidiaries.

            c.    SCANIS further agrees for itself and its successors and
                  assigns that, except in the event of termination of this
                  License Agreement by SCANIS for cause, it will not at any time
                  or in any capacity assert any claim or commence or prosecute
                  any action, suit, or proceeding against ICAD or against any
                  end user, distributor, customer, dealer, licensee or supplier
                  of ICAD, whether direct or indirect, immediate or remote,
                  based on infringement of the Licensed Patent Rights by the
                  direct and/or contributory infringement or by inducement
                  arising out of the manufacture, use, sale, offer for sale,
                  lease, import, export, or other disposition of scanners and
                  digitizers made, used, sold, offered for sale, leased,
                  imported, exported, or otherwise disposed of by or on behalf
                  of ICAD or its Subsidiaries.

            d.    Except as set forth in section 1.(d)(2), if any business
                  entity which is not a Subsidiary as of the Effective Date of
                  this Agreement becomes a Subsidiary (a "New Subsidiary"), that
                  New Subsidiary shall not have the license pertaining to the
                  Licensed Patent Rights set forth in this Agreement unless
                  SCANIS agrees in writing to the extension of this license to
                  that New Subsidiary. Nothing in this Agreement shall place any
                  obligation on SCANIS to agree to such an extension of the
                  license to a New Subsidiary.

            e.    Products manufactured by ICAD's licensees, OEM and
                  private-label customers incorporating ICAD's Licensed Products
                  receive, as to such products, the same license release and
                  non-assertion granted in this Agreement, to the extent that
                  such products infringe the Licensed Patents as a result of the
                  normal and intended use of such Licensed Products.

      4.    CONSIDERATION. In consideration of the license granted under this
            Agreement, SCANIS shall be entitled to receive the following
            consideration:

            a.    ICAD agrees to make certain digitizer products available to
                  SCANIS, as set forth in the OEM Agreement, notwithstanding the
                  fact that such products will be used by SCANIS to compete with
                  ICAD in certain markets;

            b.    SCANIS shall receive the following reduction in the per unit
                  purchase price of digitizers SCANIS purchases from HOWTEK (the
                  "Credits") pursuant to the OEM Agreement:

                  i.    As to ICAD and its Subsidiaries' MultiRAD Film Digitizer
                        (as further defined in the OEM Agreement), the Credit
                        shall be ++ per unit purchased.

                  ii.   As to ICAD and its Subsidiaries' Fulcrum Film Digitizer
                        (as further defined in the OEM Agreement), the Credit
                        shall be ++ per unit purchased.

            c.    The Credits set forth herein shall be taken within a period of
                  five years from the Effective Date of this Agreement, and
                  credits not taken within such period shall expire.

            d.    The per-unit credit granted pursuant to this paragraph shall,
                  in any case, be limited so as not to reduce HOWTEK's gross
                  margin after application of the credit to less than ++ as
                  defined by generally accepted accounting standards.

            e.    The maximum aggregate Credits SCANIS will be eligible to
                  receive under this Agreement shall be ++.

[++ represents confidential treatment request]

                                       3
<PAGE>

            f.    A Credit for any unit of a product will be deemed received by
                  SCANIS when SCANIS becomes obligated to pay for that product.
                  If a SCANIS returns a product that does not comply with the
                  warranties set forth in the OEM Agreement and receives a
                  refund of the purchase price or does not receive a replacement
                  product that comply with those warranties, the amount of the
                  Credit attributed to the purchase of that product will be
                  subtracted from the aggregate Credits SCANIS will be deemed to
                  have received.

            g.    The Credits shall be applicable only to purchases by or on
                  behalf of Scanis for use with Scanis' Computer-aided detection
                  system, by Scanis, its subsidiaries, distributors and
                  licensees. In the event of the acquisition of Scanis by any
                  third party, the Credits shall be thereafter be applicable to
                  purchases with respect to Scanis' scale and volume of overall
                  computer-aided detection business at the time of such
                  acquisition, plus annual increases equal to the greater of (1)
                  Scanis' growth rate prior to acquisition, and (2) overall
                  market growth), and shall not otherwise be assignable,
                  acquirable or assumable.

            h.    The rights and licenses granted to ICAD herein shall survive
                  termination of the Original Equipment Manufacturer Supply
                  Agreement.

      5.    TERM.

            a.    Except as provided below, the term of the licenses and
                  non-assertions granted herein shall exist from and including
                  the Effective Date to and including the expiration date of the
                  last to expire of the Licensed Patent Rights and at least
                  until all claims for alleged infringement of all such patents
                  are barred by U.S. laws and the U.S. patent statute, and by
                  the laws and statutes of any foreign country in which any one
                  of the Licensed Patent Rights are in force and effect.

            b.    Paragraph 5a notwithstanding, the license granted under
                  paragraphs 3a and 3c of this Agreement shall immediately
                  terminate upon the occurrence of either of the following
                  events:

                  i.    The license will terminate upon notice to ICAD if ICAD
                        or any it's Subsidiaries commits a material breach of
                        this Agreement, and ICAD and/or the Subsidiary in breach
                        does not cure that breach within thirty (30) days of
                        receiving notice of that breach from SCANIS.

                  ii.   The license will terminate upon notice to ICAD if it
                        files a petition for dissolution or ceases active
                        operation as a corporation.

                  iii.  The license granted to any Subsidiary of ICAD will
                        terminate with respect to that Subsidiary upon notice to
                        ICAD if the Subsidiary files a petition for dissolution
                        or ceases active operation as a corporation.

                  iv.   The termination of the license as provided in paragraph
                        6b shall not constitute a termination of any provisions
                        of this Agreement other than paragraphs 3a and 3c.

      6.    PATENT MARKING. ICAD agrees that pursuant to a request by SCANIS, it
            will mark Licensed Products or the packaging therefor with
            appropriate patent notices as may be appropriate under the Patent
            Laws of the United States and the laws of any other jurisdictions in
            which SCANIS obtains patents with respect to the inventions subject
            to the Licensed Patent Rights. Such notices shall clearly identify
            SCANIS as the owner of the Licensed Patent Rights. At SCANIS's
            request, ICAD shall provide specimens of Licensed Products and
            packaging showing patent notices to be placed upon such products and
            packaging.

      7.    PATENT ENFORCEMENT.

            a.    If ICAD becomes aware that any third party is infringing or
                  may be infringing upon the Licensed Patent Rights, ICAD agrees
                  that it will provide SCANIS with notice of such infringement.
                  ICAD agrees that it will provide SCANIS with such a notice of
                  infringement promptly, but in any event by no later than ten
                  (10) days after it becomes aware of such infringement.

                                       4
<PAGE>

            b.    SCANIS shall have the sole right to enforce and perfect the
                  Licensed Patent Rights. In this regard, SCANIS shall have the
                  sole right to take any action in response to actual or
                  possible infringement of the Licensed Patent Rights, including
                  but not limited to the right to make, in its sole discretion,
                  all decisions as to: (i) whether to commence litigation
                  against any infringer of these rights; (ii) the manner in
                  which it conducts this litigation; (iii) whether to resolve
                  such litigation through settlement; and (iv) the terms under
                  which it may settle such litigation. SCANIS reserves the
                  right, in its sole discretion, to resolve any threatened or
                  pending legal action pertaining to the Licensed Patent Rights
                  by granting a license to such third party on terms SCANIS
                  deems to be acceptable. The foregoing notwithstanding, SCANIS
                  agrees that it shall not enter into any settlement of such
                  litigation that would terminate or modify the license ICAD and
                  its Subsidiaries have received under paragraph 3 of this
                  Agreement without ICAD's prior written consent.

      8.    NO CHALLENGE TO RIGHTS - AKNOWLEDGEMENT OF OWNERSHIP.

            a.    ICAD, on behalf of itself and the Subsidiaries (but not on
                  behalf of any acquirer, successor or New Subsidiary of iCAD
                  which is, by the terms of this Agreement, denied the rights
                  granted to iCAD under paragraph 3, hereof), agrees that it
                  shall not, nor allow its Subsidiaries to: (i) challenge the
                  validity the Licensed Patent Rights or SCANIS's ownership of
                  those Licensed Patent Rights; or (ii) assert any ownership
                  interest or other interest in the Licensed Patent Rights or
                  any invention described therein other than the license granted
                  in paragraph 3 of this Agreement.

            b.    No later than two (2) weeks following the date of this
                  Agreement, ICAD shall issue a public statement announcing that
                  is has entered into this Agreement and has received a
                  non-exclusive license from SCANIS with respect to the Licensed
                  Patent Rights. The announcement shall further state that
                  SCANIS is the owner of the Licensed Patent Rights. ICAD agrees
                  that it will provide a copy of the proposed public
                  announcement no later than seventy-two (72) hours prior to its
                  scheduled release.

      9.    RELATIONSHIP OF THE PARTIES.

            a.    Nothing contained in this Agreement shall be deemed to (i)
                  make either party or any employee of such party the agent,
                  employee, joint venture or partner of the other party; (ii)
                  provide either party or any employee of such party with the
                  power or authority to act on behalf of the other party or to
                  bind the other party to any contract, agreement or arrangement
                  with any other person.

            b.    All personnel employed or otherwise engaged by either party
                  shall be the agents, servants, and employees of such party
                  only, and the other party shall incur no obligations or
                  liabilities, express or implied, by reason of the conduct of
                  such personnel.

      10.   WAIVER. Waiver by either party hereto of any breach or default by
            the other party of any of the terms and conditions of this Agreement
            shall not operate as a waiver of any other breach or default,
            whether similar to or different from the breach or default waived. A
            party may only be deemed to have waived any breach or default by the
            other party if that waiver is in writing and is signed by that
            party.

      11.   COSTS AND EXPENSES. Except as otherwise provided in this Agreement,
            each party hereto shall be responsible for its own expenses incurred
            in connection with the performance of its obligations under this
            Agreement.

      12.   ENTIRE AGREEMENT. This Agreement represents the entire understanding
            and agreement between the parties hereto with respect to the subject
            matter of this Agreement and supersedes all prior negotiations,
            representations, and agreements made by and between the parties
            concerning that subject matter. No alteration, amendment or
            modification of any of the terms or provisions of this Agreement
            shall be valid unless made pursuant to an instrument in writing
            signed by each of the parties hereto; provided, however, that the
            waiver by either party hereto of compliance by the other party with
            any provision hereof or of any breach or default of such other party
            need be signed only by the party waiving such provision, breach or
            default. The foregoing notwithstanding, nothing in this Agreement
            shall constitute the termination or amendment of any agreement
            between SCANIS and HOWTEK.

      13.   GOVERNING LAW. This Agreement shall be governed by and interpreted
            in accordance with the laws of the State of New York, excluding that
            state's conflict of laws principles.

                                       5
<PAGE>

      14.   NON-ASSIGNMENT.

            a.    Except as expressly provided herein, ICAD and its Subsidiaries
                  may not assign their rights under this Agreement to any other
                  person or entity, whether by operation of law or otherwise,
                  without the prior written consent of SCANIS, which may be
                  withheld in SCANIS' sole discretion. Any assignment or
                  purported assignment by ICAD or any Subsidiaries in violation
                  of this paragraph shall be null and void.

            b.    Notwithstanding the above, in the event of the acquisition of
                  iCAD by another party, the licenses granted under paragraph 3
                  shall remain effective with respect to Licensed Products
                  equivalent in annual sales value to the annual sales value of
                  Licensed Products by iCAD and its Subsidiaries as of the time
                  of such acquisition, plus annual increases equal to the
                  greater of (1) iCAD's and its Subsidiairies' growth rate prior
                  to acquisition, and (2) overall market growth.

            c.    Subject to paragraph 4(g), SCANIS may assign its rights under
                  this Agreement, and this Agreement shall be binding upon and
                  inure to the benefit of SCANIS's assignees and successors.

      15.   NOTICES. All notices provided for in this Agreement shall be
            effective when they are served either by personal delivery, or sent
            by letter by overnight courier service with acknowledgment of
            receipt required and simultaneously sent by facsimile to the
            receiving party at the following address:

                         If to ICAD:

                         Chief Executive Officer
                         iCAD, Inc.
                         4 Townsend West, Suite 17, Nashua, NH 03063
                         Fax: (603) 880-3843

                         If to SCANIS:
                         Chief Executive Officer
                         SCANIS, INC.
                         1111 Triton Drive, Suite 201, Foster City, CA 94494
                         Fax: (650) 378-4109

                         With a copy to:

                         Frederick K. Koenen
                         Foley & Lardner
                         One Maritime Plaza, Sixth Floor
                         San Francisco, CA  94111
                         Fax: (415) 434-4507

      or such other addresses either party shall hereinafter designate in
      writing to the other party.

                                       6
<PAGE>

      16.   INVALIDITY OF PROVISIONS. If a court of competent jurisdiction
            determines that any provision of this Agreement is unenforceable, it
            is agreed that such unenforceability shall not invalidate the whole
            agreement, but this Agreement shall be construed as if it did not
            contain such provisions, insofar as such construction does not
            materially affect the overall benefit of the bargain evidenced in
            this Agreement, and the rights and obligations of the parties hereto
            shall be construed and enforced accordingly. If deletion of the
            unenforceable provision would materially affect the overall benefit
            of the bargain of the parties, this Agreement shall immediately
            terminate.

      17.   BANKRUPTCY. The parties understand that all rights and licenses
            granted hereunder are licenses to rights to intellectual property
            under Section 365(n) of the Bankruptcy Act and, therefore, if SCANIS
            becomes subject to bankruptcy proceedings, ICAD and the Subsidiaries
            shall retain and may fully exercise all of their rights and
            elections under the Bankruptcy Code as licensees of that
            intellectual property.

      18.   ATTORNEYS' FEES. If any action is commenced to enforce or construe
            this Agreement, the Party who substantially prevails in that action
            shall be entitled to recover all costs and expenses that Party
            incurs in the prosecution or defense of that action, including but
            not limited to reasonable attorneys' fees, in addition to any other
            relief to which that Party is entitled.

      19.   LATE PAYMENTS. Amounts owing under this Agreement that are not made
            when due shall accrue interest at a rate of one percent (1.0%) per
            month or the maximum amount of interest allowed under applicable law
            (whichever is less) until such amounts are paid in full.

      20.   TITLES. All titles used in this Agreement herein are for the
            convenience of reference only and shall not affect the construction
            of this Agreement.

      21.   DUPLICATE ORIGINALS. This Agreement shall be executed in duplicate
            originals and may first be delivered by facsimile. Execution of this
            Agreement by the parties and delivery thereof by facsimile shall be
            valid and binding as of the Effective Date, which will be inserted
            in the preamble. This Agreement may be executed separately by each
            of the parties and exchanged by facsimile to establish the Effective
            Date. Within thirty (30) days of facsimile execution, the parties
            shall deliver and exchange fully executed originals of the
            Agreement.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed, in duplicate, by their duly authorized officers or representatives.

SCANIS, INC.

By: /s/ Robert L. Chapman
    ------------------------------

Its. Chief Executive Officer

Witness:        /s/ Christine V. Evans
                ----------------------

iCAD, Inc.

By: /s/ W. Scott Parr
    ------------------------------
       W. Scott Parr

Its. President and Chief Executive Officer
     -------------------------------------

Witness:        /s/ William Langille
                --------------------

                                       7
<PAGE>

                          EXHIBIT 1 - Licensed Patents

"Licensed Patents" shall mean:

      1.    U.S. Patent No. 5,212,637 of May 18, 1993 ("the `637 Patent") and
            any and all parents, divisions, continuations,
            continuations-in-part, reissues or reexaminations of that patent, as
            well as any and all foreign patents or foreign patent applications
            (including utility models) corresponding to said U.S. patent, along
            with any and all parents, divisions, continuations,
            continuations-in-part, substitutions or additions to any of the
            foregoing foreign patents.

      2.    Canadian Patent No. 2,069,429 and any and all parents, divisions,
            continuations, continuations-in-part, reissues or reexaminations of
            that patent.

      3.    Japanese Patent No. 3,121,008 and any and all parents, divisions,
            continuations, continuations-in-part, reissues or reexaminations of
            that patent.

      4.    Patent to be issued pursuant to European Patent Application No.
            90917158.9, claims for which were approved on January 14, 2003 and
            any and all parents, divisions, continuations,
            continuations-in-part, reissues or reexaminations of that patent.

                                       8
<PAGE>

      EXHIBIT 2 - Current Subsidiaries

1.    Howtek Devices Corporation

2.    ISSI Acquisition Corporation

                                       9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}]]